|

Upadacitinib 15 MG [Rinvoq] Clinical Trials

2 actively recruiting trials across 1 location

Also known as: Rinvoq

Pipeline

Phase 4: 1

Top Sponsors

  • I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio1
  • CARE ARTHRITIS LTD.1

Indications

  • Arthritis2
  • Spondyloarthritis, Axial1
  • Rheumatoid Arthritis (RA1
  • Psoriatic Arthritis1
  • Psoriatic Arthritis (PsA)1

Other1 trial

Efficacy Of Upadacitinib In Psoriatic Arthritis And Comparison To Rheumatoid Arthritis.

Portland, Oregon1 trial

A Study to Evaluate the Impact of Upadacitinib on Spondyloarthritis Outcomes in Patients With Active Psoriatic Arthritis

Oregon Health and Science University

Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.